Playback speed
10 seconds
ASCO® 2023 Insights: "ADAURA Trial - OS With Osimertinib for Patients With Resectable/Resected EGFR+ NSCLC"
92 views
July 21, 2023
Comments 0
Login to view comments.
Click here to Login
Recommended
AUTOPLAY